ACP
MIST icon

Acuta Capital Partners’s Milestone Pharmaceuticals MIST Stock Holding History

Acuta Capital Partners’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-597,026
Closed -$5.49M – 42
2022
Q3 		$5.49M Buy
597,026
+139,826
+31% +$1.06M 2.36% 17
2022
Q2 		$2.81M Buy
457,200
+77,200
+20% +$474K 1.57% 21
2022
Q1 		$2.44M Buy
+380,000
New +$2.37M 1.14% 27
2020
Q1 		– Sell
-508,500
Closed -$8.14M – 37
2019
Q4 		$8.14M Buy
508,500
+139,000
+38% +$2.46M 2.02% 16
2019
Q3 		$6.89M Buy
369,500
+22,500
+6% +$443K 4.97% 7
2019
Q2 		$9.42M Buy
+347,000
New +$7.16M 3.35% 12

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acuta Capital Partners's MIST Position: Q4 2022 in Review

Acuta Capital Partners sold out of Milestone Pharmaceuticals (MIST) in Q4 2022, closing a stake of 597,026 shares — an estimated $5.49M sold.

Acuta Capital Partners first reported a position in MIST in Q2 2019 and held it in 6 quarters. The position peaked at $9.42M in Q2 2019. 56 funds tracked by Wall St. Rank hold MIST as of Q4 2022.

  • Acuta Capital Partners reported no remaining Milestone Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Acuta Capital Partners sold 597,026 Milestone Pharmaceuticals shares in Q4 2022, an estimated $5.49M.
  • Acuta Capital Partners first reported a position in Milestone Pharmaceuticals in Q2 2019 and held it in 6 quarters.
  • Acuta Capital Partners's Milestone Pharmaceuticals position peaked at $9.42M in Q2 2019.
  • 56 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2022.

Based on Acuta Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.